Not provided
Not provided
Not provided
Not provided
Not provided
Due to the COVID-19 pandemic
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this pilot RCT, a total of 40 adults with hypertension will be randomized to either an artificial intelligence (AI) physical activity intervention group or an active control group with a 1 to 1 ratio after completing a 2-week run-in period and 4-week training. The AI intervention group will receive an automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning, while the active control group will receive a standardized and fixed 10,000 daily steps goal. Both groups will receive an identical smartphone app (app content differs between the two groups) and ActiGraph GT9X Link to assess objectively measured physical activity (primary outcome) during the study period.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Artificial Intelligence (AI) Activity group | Experimental | Participants in this group receive an AI based intervention (automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning and message) |
|
| Control group | Active Comparator | Participants in this group receive a standardized and fixed 10,000 daily steps goal intervention. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Artificial Intelligence (AI) Activity | Behavioral | The intervention provides participants with an automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning. |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in weekly daily average steps | measured by ActiGraph GT9X Link] | Baseline (run-in period), 4 week-test period, and 3-month intervention period |
| Duration (minutes) of moderate to vigorous intensity physical activity (MVPA) per day | measured by ActiGraph GT9X Link] | Baseline (run-in period), 4 week-test period, and 3-month intervention period |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Systolic blood pressure (SBP) | Baseline (run-in period), 4 week-test period, and 3-month intervention period | |
| Changes in diastolic blood pressure (DBP) | Baseline (run-in period), 4 week-test period, and 3-month intervention period |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yoshimi Fukuoka, PhD, RN, FAAN | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94118 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001185 | Artificial Intelligence |
| D015444 | Exercise |
| ID | Term |
|---|---|
| D000465 | Algorithms |
| D055641 | Mathematical Concepts |
| D009043 | Motor Activity |
| D009068 | Movement |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 10,000 steps | Behavioral | The intervention provides participants with an automated daily 10,000 step goal intervention |
|
| aortic stiffness | measured by SphigmoCor XCEL system | Baseline (run-in period), 4 week-test period, and 3-month intervention period |
| sodium intake | as measured in 24-hour urine samples | Baseline (run-in period), 4 week-test period, and 3-month intervention period |
| Changes in weight | Baseline (run-in period), 4 week-test period, and 3-month intervention period |
| Changes in Body Mass Index (BMI) | using weight and height to calculate | Baseline (run-in period), 4 week-test period, and 3-month intervention period |
| D009142 |
| Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |